{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:38:56Z","timestamp":1793392736637,"version":"4.5.0"},"reference-count":10,"publisher":"Consortium of Multiple Sclerosis Centers","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>The experience with spasticity varies among individuals with multiple sclerosis and spasticity (MSS), as they may not recognize it as spasticity or have the language to describe their symptoms. This can lead to potential delays in diagnosis and treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>Symptoms and Emotions Exploration Needed in Multiple Sclerosis Spasticity was an online survey completed by 1177 individuals with MSS in 2021. It sought to capture symptoms of spasticity, variability of symptoms, specific spasticity triggers, and how conversations with physicians were initiated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>The mean age of the cohort was 56.8 years and it was 78% women. Prior to spasticity onset, 65% of respondents felt minimally prepared or unprepared for possibly developing spasticity and were unaware that spasticity manifests as part of MS. Eighty percent experienced spasticity daily, which was variable in severity and duration. Spasticity was triggered by a range of factors and 90% of those surveyed were unable to predict when it would occur or its severity. Day-to-day variability of spasticity prevented 65% of respondents from doing things they wished to do. Sixty percent were confused by their symptoms, not recognizing them as spasticity. Although 91% reported experiencing muscle spasms, only 69% used \u201cmuscle spasms\u201d to describe their symptoms. Other descriptors included \u201cmuscle tightness,\u201d \u201cstiffness,\u201d \u201ccramping,\u201d and \u201cpain.\u201d After recognizing spasticity, 78% proactively initiated discussions with their physicians, 52% wished they had done so sooner, and 42% delayed the conversation by up to or more than a year.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Results emphasize the variable nature of spasticity and the lack of a common language to describe symptoms, underscoring the importance of education, earlier recognition, and customized treatments tailored to the severity and duration of spasticity symptoms.<\/jats:p>\n               <\/jats:sec>","DOI":"10.7224\/1537-2073.2022-115","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T03:43:31Z","timestamp":1693194211000},"page":"75-80","source":"Crossref","is-referenced-by-count":4,"title":["Recognition, Description, and Variability of Spasticity in Individuals With Multiple Sclerosis and Potential Barriers to Clinician-Patient Dialogue: Results From SEEN-MSS, a Large-Scale, Self-Reported Survey"],"prefix":"10.7224","volume":"26","author":[{"given":"Ben","family":"Thrower","sequence":"first","affiliation":[{"name":"From the Andrew C. Carlos Multiple Sclerosis Institute, Shepherd Center, Atlanta, GA (BT)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Newsome","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, MD (SDN)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Hendin","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Arizona College of Medicine, Tucson, AZ (BH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Danese","sequence":"additional","affiliation":[{"name":"Outcomes Insights, Ventura County, CA (SD)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Patterson","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Inc, Seattle, WA (JP, RC)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Chinnapongse","sequence":"additional","affiliation":[{"name":"Jazz Pharmaceuticals, Inc, Seattle, WA (JP, RC)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4242","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"issue":"14","key":"2024030714301880200_i1537-2073-26-2-75-b1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"2024030714301880200_i1537-2073-26-2-75-b2","doi-asserted-by":"publisher","first-page":"20406223211069198","DOI":"10.1177\/20406223211069198","article-title":"Effects of non-invasive brain stimulation in multiple sclerosis: systematic review and meta-analysis","volume":"13","author":"Kan","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"issue":"6","key":"2024030714301880200_i1537-2073-26-2-75-b3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40271-016-0173-0","article-title":"A cross-sectional study of the impact of spasticity on daily activities in multiple sclerosis","volume":"9","author":"Bethoux","year":"2016","journal-title":"Patient"},{"issue":"5","key":"2024030714301880200_i1537-2073-26-2-75-b4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"10","author":"Rizzo","year":"2004","journal-title":"Mult Scler"},{"key":"2024030714301880200_i1537-2073-26-2-75-b5","volume-title":"Spasticity","author":"National Institute of Neurological Disorders and Stroke (NINDS)"},{"issue":"11","key":"2024030714301880200_i1537-2073-26-2-75-b6","doi-asserted-by":"publisher","first-page":"CD008929","DOI":"10.1002\/14651858.CD008929.pub2","article-title":"Interventions for managing skeletal muscle spasticity following traumatic brain injury","volume":"11","author":"Synnot","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2024030714301880200_i1537-2073-26-2-75-b7","doi-asserted-by":"publisher","DOI":"10.2196\/17928","article-title":"Perspective of an international online patient and caregiver community on the burden of spasticity and impact of botulinum neurotoxin therapy: survey study","volume":"6","author":"Patel","year":"2020","journal-title":"JMIR Public Health Surveill"},{"issue":"3","key":"2024030714301880200_i1537-2073-26-2-75-b8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1756285611403646","article-title":"Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice","volume":"4","author":"de Sa","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"2024030714301880200_i1537-2073-26-2-75-b9","doi-asserted-by":"publisher","first-page":"104376","DOI":"10.1016\/j.msard.2022.104376","article-title":"Symptom burden, management and treatment goals of people with MS spasticity: results from SEEN-MSS, a large-scale, self-reported survey","volume":"68","author":"Newsome","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"2024030714301880200_i1537-2073-26-2-75-b10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/00207454.2012.762364","article-title":"Spasticity in multiple sclerosis: results of a patient survey","volume":"123","author":"Oreja-Guevara","year":"2013","journal-title":"Int J Neurosci"}],"container-title":["International Journal of MS Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/26\/2\/75\/3340055\/i1537-2073-26-2-75.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/26\/2\/75\/3340055\/i1537-2073-26-2-75.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T21:12:53Z","timestamp":1752786773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijmsc.org\/view\/recognition-description-and-variability-of-spasticity-in-individuals-with-multiple-sclerosis-and-potential-barriers-to-clinician-patient-dialogue-results-from-seen-mss-a-large-scale-self-reported-survey"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3,6]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.7224\/1537-2073.2022-115","relation":{},"ISSN":["1537-2073"],"issn-type":[{"value":"1537-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}